FormDSignal
47

Halia Therapeutics, Inc. raises $3.5M under Reg D

Company raise · Raising · LEHI, UT · Form D filed 2026-08-31
$10M+ raise

Why now — by persona

Relevant to: Executive & technical recruiting, B2B software & services sales, Commercial banking / treasury, D&O and management-liability insurance, Outsourced accounting / CFO. Lead card pending.

People on the filing

Preston B. CampbellDirector
Mary B. BeckerleDirector
David CheckettsDirector
Gary B. SabinDirector
Jeffrey BurtonExecutive Officer
David BearssDirector
John S.K. KauweDirector

Signed by Jeffrey Burton, Chief Financial Officer.

Filing contact

The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.

Other filings by this issuer